Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

SELL
$27.57 - $32.91 $799 - $954
-29 Reduced 96.67%
1 $0
Q2 2023

Aug 08, 2023

BUY
$29.91 - $38.73 $897 - $1,161
30 New
30 $629,000
Q2 2022

Aug 05, 2022

SELL
$25.33 - $34.25 $14,590 - $19,728
-576 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$28.51 - $32.9 $16,421 - $18,950
576 New
576 $2.9 Million
Q3 2021

Nov 12, 2021

SELL
$23.54 - $31.39 $2,448 - $3,264
-104 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$26.72 - $33.19 $454 - $564
-17 Reduced 14.05%
104 $31,000
Q1 2021

May 17, 2021

BUY
$24.15 - $31.45 $2,922 - $3,805
121 New
121 $3.17 Million
Q4 2019

Feb 28, 2020

SELL
$19.93 - $29.13 $318 - $466
-16 Closed
0 $0
Q3 2019

Oct 15, 2019

BUY
$25.47 - $33.37 $101 - $133
4 Added 33.33%
16 $0
Q2 2019

Jul 26, 2019

SELL
$29.96 - $38.87 $36,221 - $46,993
-1,209 Reduced 99.02%
12 $0
Q1 2019

Apr 19, 2019

BUY
$32.77 - $41.99 $38,471 - $49,296
1,174 Added 2497.87%
1,221 $44,000
Q3 2018

Oct 31, 2018

SELL
$42.7 - $56.55 $469 - $622
-11 Reduced 18.97%
47 $2,000
Q2 2018

Aug 14, 2018

BUY
$44.1 - $59.85 $1,323 - $1,795
30 Added 107.14%
58 $3,000
Q1 2018

May 23, 2018

BUY
$37.15 - $46.9 $1,040 - $1,313
28 New
28 $1,000

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.